Doctor profile · Federal record

Dr. Kemunto Mokaya, M.D.

Dermatology Physician (CMS: Dermatology) · Dermatology Physician · Pediatric Dermatology Physician · Pediatric Dermatology Physician · Procedural Dermatology Physician · Procedural Dermatology Physician · Conroe, TX

  • NPI 1396065769
  • Accepts Medicare
  • MIPS 99.2 / 100 · 2023
  • 16 yrs in practice
  • Licensed in 2 states
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
508 Medical Center Blvd Ste 380
Conroe, TX 773042954
(281) 573-8333
fax (936) 703-5323

Credentials & registration

NPPES · NUCC
NPI registered
June 2010 — 16 yrs on file
Profile last updated
April 25, 2022
Year of graduation
2010 — 16 yrs since
Specialty taxonomy
207N00000X — NUCC code
State licenses (4)
Texas #T5629 · Tennessee #MD0000051717 · Texas #207NS0135X · Tennessee #MD000051717

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1396065769. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
2,754
Distinct HCPCS
10
Medicare allowed
$149,184
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 1,078 185 $6
17000 Destruction of precancer skin growth, 1 growth 305 237 $44
99214 Established patient office or other outpatient visit, 30-39 minutes 222 145 $122
17110 Destruction of skin growth, 1-14 growths 211 172 $100
88305 Pathology examination of tissue using a microscope, intermediate complexity 191 116 $33
99213 Established patient office or other outpatient visit, 20-29 minutes 150 121 $84
99204 New patient office or other outpatient visit, 45-59 minutes 113 113 $158
99203 New patient office or other outpatient visit, 30-44 minutes 102 102 $107
11102 Biopsy of related skin growth, first growth 80 75 $79
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 57 15 $1

In context: peer comparison

Among 2 peers in this city , average services per provider: 178. This provider delivers 15× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,159
Transactions
138
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
ABBVIE INC. 27 $552.81
Regeneron Healthcare Solutions, Inc. 7 $349.00
SUN PHARMACEUTICAL INDUSTRIES INC. 13 $282.79
Lilly USA, LLC 12 $270.48
Janssen Biotech, Inc. 8 $269.92
Galderma Laboratories, L.P. 10 $239.99
E.R. Squibb & Sons, L.L.C. 13 $204.40
PFIZER INC. 15 $170.65
Novartis Pharmaceuticals Corporation 8 $145.05
Incyte Corporation 6 $130.94
UCB, Inc. 3 $92.52
Dermavant Sciences, Inc. 5 $91.80
GENZYME CORPORATION 3 $80.77
Amgen Inc. 4 $69.06
Arcutis Biotherapeutics, Inc. 4 $66.53

By nature of payment

Food and Beverage
$3,051
Education
$108

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
675
Patients
414
Total drug cost
$23,610
Drug Type Claims Patients Total cost
Triamcinolone Acetonide Generic 147 94 $1,476
Ketoconazole Generic 114 69 $2,142
Mupirocin Generic 69 51 $489
Clobetasol Propionate Generic 54 32 $2,039
Fluocinonide Generic 52 40 $2,801
Tacrolimus Generic 39 29 $8,698
Doxycycline Monohydrate Generic 37 24 $796
Metronidazole Generic 30 17 $1,767
Nystatin Generic 29 14 $628
Fluconazole Generic 21 15 $147

Frequently asked questions

Auto-generated from federal data
What is Dr. Kemunto Mokaya's medical specialty?
Dr. Kemunto Mokaya practices Dermatology Physician in Conroe, TX.
Where does Dr. Kemunto Mokaya practice?
Dr. Kemunto Mokaya practices at 508 Medical Center Blvd Ste 380, Conroe, TX 773042954. Office phone: 2815738333.
What is Dr. Kemunto Mokaya's NPI?
Dr. Kemunto Mokaya's National Provider Identifier (NPI) is 1396065769, issued by NPPES.
Does Dr. Kemunto Mokaya accept Medicare assignment?
Yes. Dr. Kemunto Mokaya accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kemunto Mokaya commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.